Wednesday, December 18, 2019, 10:00 a.m. EDT
Findings give new insights into the connection between poor air quality, children’s health, and mother’s health
A new report from the National Toxicology Program (NTP) suggests that traffic-related air pollution increases a pregnant woman’s risk for dangerous increases in blood pressure, known as hypertension.
NTP scientists evaluated published research on the link between traffic-related air pollution, or TRAP, and hypertensive disorders broken down by pollutant measurements of TRAP, such as particulate matter (PM2.5). PM is the term for a mixture of solid particles and liquid droplets found in the air, and PM2.5 refers to fine inhalable particles, with diameters that are generally 2.5 micrometers or smaller. The average human hair is about 70 micrometers in diameter, about 30 times larger than the largest fine particle.
“What we found when we reviewed the literature is that exposure to PM2.5 from traffic emissions was associated with development of hypertensive disorders in pregnant women,” said Brandy Beverly, Ph.D., lead scientist and researcher at the National Institute of Environmental Health Sciences, part of the National Institutes of Health. “When these women are exposed to PM2.5 during their entire pregnancy, the likelihood of developing preeclampsia increases by about 50%.”
Other components of TRAP that NTP evaluated included nitrogen oxides, carbon monoxide, black carbon, and elemental carbon, along with parameters like traffic density and mothers’ proximity to main roads.
For example, the literature suggests that women who live within a quarter of a mile of a major roadway or in high traffic density regions may be at an increased risk for developing hypertensive disorders of pregnancy.
TRAP comes from the combustion of fossil fuels by motor vehicles. These vehicle emissions are mixtures of gases and particles that are easily inhaled and have adverse health effects. TRAP is known to be a major risk factor for cardiovascular disease, including hypertension.
Hypertensive disorders of pregnancy complicate more than 10% of pregnancies worldwide and are a leading cause of maternal and fetal illness and death. According to the American College of Obstetrics and Gynecology, mothers with hypertension during pregnancy are more likely to have a pre-term delivery. Their infants are at greater risk for low birthweight and a range of long-term health problems associated with pre-mature birth.
“Hypertensive disorders of pregnancy refer to a range of clinical conditions, all of which include high blood pressure during pregnancy,” said Beverly. “The disorders are classified into four distinct types, based on differences in the timing and onset of the symptoms.”
Pregnant women may experience four types of hypertensive disorders:
- Gestational hypertension, or high blood pressure, in the second half of pregnancy.
- Preeclampsia, or high blood pressure with protein in urine or impaired liver or kidney function, in the second half of pregnancy. If preeclampsia worsens and causes seizures, it becomes eclampsia – a serious condition for mother and child with the potential to be fatal.
- Chronic hypertension, or high blood pressure before pregnancy or early in pregnancy, that continues throughout pregnancy.
- Chronic hypertension with preeclampsia, or high blood pressure before pregnancy or early in pregnancy, that continues throughout pregnancy and is complicated by new onset protein in the urine or impaired liver or kidney function.
Using their standard four-tier scale to classify human hazards, NTP looked at the combined evidence from the individual components and concluded that TRAP is a presumed human hazard for hypertensive disorders during pregnancy, though they weren’t able to distinguish between the four types of disorders. The scale ranges from the highest hazard rating of “known”, followed by “presumed”, then “suspected”, and finally, “not classifiable”.
NTP conducted the systematic review of published research on hypertensive disorders in pregnant women and its link to TRAP after receiving a nomination from several pediatricians to evaluate the connection between emerging issues associated with air pollution and children’s health.
NTP scientists performed a comprehensive literature search and reviewed hundreds of studies with potentially relevant data. Overall, they evaluated 18 human observational studies and one animal study that specifically addressed hypertension during pregnancy and TRAP. Usually, experimental animal data add confidence in the conclusions; unfortunately, the limited number of animal studies that assessed the impact of environmental exposures during pregnancy is a research gap.
The evaluation underwent external peer review involving experts from academia and industry, who evaluated NTP’s draft conclusions and agreed unanimously with NTP’s final conclusion.
The National Toxicology Program (NTP) is a federal, inter-agency program within the U.S. Department of Health and Human Services. Three federal agencies comprise NTP, National Institute of Environmental Health Sciences, part of NIH, the National Center for Toxicological Research, part of the U.S. Food and Drug Administration, and the National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention.
About the National Institute of Environmental Health Sciences (NIEHS): NIEHS supports research to understand the effects of the environment on human health and is part of the National Institutes of Health. For more information on NIEHS or environmental health topics, visit www.niehs.nih.gov or subscribe to a news list.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health®
EHP Names New Editor-in-chief